Open original FDA record ↗Recall record
- FDA identifier
- Z-0900-2022
- Company in FDA record
- Kaneka America Corp
- FDA record creation date
- Apr 9, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Labeling change to due to the risk of severe anaphylactoid reactions including shock in patients treated with the Liposorber LA-15 LDL Adsorption Column under concomitant ACE inhibitor medication treatment.
Source facts
- Action
- On 02/17/2022 a recall notification letter with revised labeling was emailed regarding contraindication in patients who are being treated with angiotensin-converting enzyme (ACE) inhibitors. Customers are to locate, destroy and replace all operator's manuals, patient guides, and IFUs with those attached to the recall notice, ensuring they are distributed to all end users. All device model, lot, and UDI numbers for systems and disposables are affected. Submit the Acknowledgement and Receipt Form to Kaneka Medical America, LLC via email. If you have any question or concerns about this recall please contact Kaneka Medical America LLC Monday through Friday, 8:00 AM to 4:30 PM, Eastern Time, at: Phone: (212) 705-4355, Email: Ahmad.Al-Sattari@kaneka.com
- Initiated
- 2022-02-17
- Root cause
- Error in labeling
- Terminated
- 2024-05-06
- Distribution
- US only: CA, NH, CT, MA, FL, DE, NY, NJ, PA, OH, MD, VA, NC, SC, GA, MS, TN, TX, IN, AZ, MI, WI, MN, IL, MO, NE, CO, WA, OR, UT, KS, OK, AL, ME
- Recall number
- Z-0900-2022
- Recall status
- Terminated
- CDRH record ID
- 192323
- FDA record created
- 2022-04-09
- Recall event number
- 89735